Global Pulmonary Drugs Market Share

Statistics for the 2023 & 2024 Global Pulmonary Drugs market share, created by Mordor Intelligence™ Industry Reports. Global Pulmonary Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Pulmonary Drugs Industry

The global pulmonary drugs market is highly competitive and consists of a number of major players. Companies like AstraZeneca, Boehringer Ingelheim, AstraZeneca PLC, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Grifols, S.A., Merck & Co., Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., and Teva Pharmaceutical Industries Ltd. hold the substantial market share in the Pulmonary Drugs market.

Pulmonary Drugs Market Leaders

  1. Boehringer Ingelheim

  2. Merck & Co.

  3. AstraZeneca PLC

  4. GlaxoSmithKline PLC

  5. Grifols, S.A.

*Disclaimer: Major Players sorted in no particular order

Pulmonary Drugs Market Concentration

Pulmonary Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)